drugset / Trial / NCT02608216
[18F]FLT PET/CT in Rb+ Metastatic Breast Cancer
NaSingle-groupOpen-labelDiagnostic
Summary
In this study positron emission tomography (PET/CT) imaging will be used to evaluate proliferative activity in sites of metastatic disease using the investigational radiotracer \[18F\]fluorothymidine (FLT).
Timeline
- Start
- 2015-11
- Primary completion
- 2026-11
- Completion
- 2026-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Background | Paclitaxel | Small molecule | — | — |
| Background | Ribociclib | Small molecule | — | — |